A review of six placebo-controlled medical trials with 1,134 overall members concluded that cannabinoids (nabiximols, dronabinol, and THC/CBD) had been connected with a increased common advancement to the Ashworth scale for spasticity in numerous sclerosis individuals as opposed with placebo, Despite the fact that this did not reach statistical importance. https://cristiannebbq.blogpostie.com/57832001/not-known-factual-statements-about-cannabis-world-vienna